isirv Antiviral Group
The AVG committee co-ordinates the various activities and represent the interests of the isirv-AVG. Its composition reflects the range of interests and activities of the AVG and where possible is geographically representative. Committee members have responsibility for organizing particular activities of the group and/or collating information on particular subject areas for the website or publication, and integrating contributions from the AVG membership.
Members are elected for a period of two years. The mechanism for electing new members to the committee is consistent with that adopted for election to the isirv Board.
Membership will be reviewed at annual meetings of the AVG and was last reviewed at the inaugural Annual Meeting in Rio de Janeiro, 10 November 2011. Currently the Chair of the committee is Alan Hay and Co-chair is Arnold Monto, for a period of two years.
|Elena Govorkova||St Jude Children's Research Hospital, Memphis, USA|
|Larisa Gubareva||Centers for Disease Control and Prevention, Atlanta, USA|
|Alan Hay||National Institute for Medical Research, London, UK|
|Frederick Hayden||University of Virginia School of Medicine, Charlottesville, USA|
|Aeron Hurt||WHO Influenza Collaborating Centre, Melbourne, Australia|
|Robert Krug||University of Texas at Austin, Austin, USA|
|Jenny McKimm-Breschkin||CSIRO, Melbourne, Australia|
|Adam Meijer||National Institute for Public Health, Bilthoven, The Netherlands|
|Arnold Monto||University of Michigan School of Public Health, Ann Arbor, USA|
|Charles Penn||World Health Organisation, Geneva, Switzerland|
|Marilda Siqueira||Fiocruz, Rio de Janeiro, Brazil|
|Norio Sugaya||Keiyu Hospital, Yokohama, Japan|
|Sylvie van der Werf||Institut Pasteur, Paris, France|
|Maria Zambon||Health Protection Agency, London, UK|